NL6617500A - - Google Patents

Info

Publication number
NL6617500A
NL6617500A NL6617500A NL6617500A NL6617500A NL 6617500 A NL6617500 A NL 6617500A NL 6617500 A NL6617500 A NL 6617500A NL 6617500 A NL6617500 A NL 6617500A NL 6617500 A NL6617500 A NL 6617500A
Authority
NL
Netherlands
Application number
NL6617500A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6617500A publication Critical patent/NL6617500A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F23—COMBUSTION APPARATUS; COMBUSTION PROCESSES
    • F23K—FEEDING FUEL TO COMBUSTION APPARATUS
    • F23K3/00—Feeding or distributing of lump or pulverulent fuel to combustion apparatus
    • F23K3/10—Under-feed arrangements
    • F23K3/14—Under-feed arrangements feeding by screw

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Combustion & Propulsion (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL6617500A 1965-12-13 1966-12-13 NL6617500A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51359965A 1965-12-13 1965-12-13
US513553A US3412193A (en) 1965-12-13 1965-12-13 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility

Publications (1)

Publication Number Publication Date
NL6617500A true NL6617500A (ja) 1967-06-14

Family

ID=27057915

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6617500A NL6617500A (ja) 1965-12-13 1966-12-13

Country Status (7)

Country Link
US (1) US3412193A (ja)
BE (1) BE691049A (ja)
CH (1) CH476001A (ja)
DE (1) DE1620057C3 (ja)
FR (1) FR1504326A (ja)
GB (1) GB1129393A (ja)
NL (1) NL6617500A (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3597429A (en) * 1968-02-15 1971-08-03 Miles Lab Derivatives of tetrazolyl alkanoic acids
GB1265866A (ja) * 1968-08-23 1972-03-08
US3884922A (en) * 1969-07-31 1975-05-20 Yoshitomi Pharmaceutical 11-(4-Pyridylalkyl-piperazino)-dibenzothiazepines
US4049809A (en) * 1976-11-24 1977-09-20 American Cyanamid Company Solution of a oxazepine for oral or parenteral administration
GB1587128A (en) * 1977-04-07 1981-04-01 Hexachimie Benzothiazepine derivatives
US5223497A (en) * 1989-03-31 1993-06-29 Yale University Treating habit disorders
US5114942A (en) * 1989-03-31 1992-05-19 Yale University Treating habit disorders
US5059600A (en) * 1989-03-31 1991-10-22 Yale University Treating habit disorders
EP1047425A4 (en) * 1997-12-17 2009-04-22 Merck & Co Inc INTEGRIN RECEPTOR ANTAGONISTS
US6890919B2 (en) * 2001-06-26 2005-05-10 Shitij Kapur Atypical antipsychotic agents having low affinity for the D2 receptor
US7388954B2 (en) * 2002-06-24 2008-06-17 Freescale Semiconductor, Inc. Method and apparatus for tone indication
WO2004056182A1 (en) * 2002-12-20 2004-07-08 Basf Aktiengesellschaft Pesticidal dibenzo(hetero)azepine derivatives
US20050250767A1 (en) * 2003-01-23 2005-11-10 Weiner David M Use of N-desmethylclozapine to treat human neuropsychiatric disease
RU2336879C2 (ru) * 2003-01-23 2008-10-27 Акадиа Фармасьютикалз Инк. Применение n-десметилклозапина для лечения нейропсихиатрических заболеваний у людей
CN100398536C (zh) 2003-08-20 2008-07-02 爱密斯菲尔科技公司 用于口服传递glp-1化合物或mc4激动剂肽的化合物、方法和制剂
ES2278346T3 (es) 2003-08-20 2007-08-01 Eli Lilly And Company Compuestos, procedimientos y formulaciones para suministro oral de un compuesto peptido (glp)-1 del tipo de glucagon o un peptido agonista (glp)-4 del receptor 4 de melacortina (mc4).
JP2007534656A (ja) 2003-12-22 2007-11-29 アカディア ファーマシューティカルズ，インコーポレーテッド ムスカリンアゴニストとしてのアミノ置換ジアリール［ａ，ｄ］シクロヘプテン類似体および精神神経疾患の治療方法
US20050282800A1 (en) * 2004-04-01 2005-12-22 Bo-Ragnar Tolf Method of synthesis and isolation of solid N-desmethylclozapine and crystalline forms thereof
US20070105836A1 (en) * 2005-10-31 2007-05-10 Lars Pettersson Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
KR20110019781A (ko) 2008-06-20 2011-02-28 아스트라제네카 아베 디벤조티아제핀 유도체 및 그의 용도

Also Published As

Publication number Publication date
DE1620057C3 (de) 1978-06-08
US3412193A (en) 1968-11-19
BE691049A (ja) 1967-05-16
FR1504326A (fr) 1967-12-01
GB1129393A (en) 1968-10-02
CH476001A (de) 1969-07-31
DE1620057B2 (de) 1977-10-06
DE1620057A1 (de) 1970-03-19

Similar Documents

Publication Publication Date Title
DE1488726A1 (ja)
FR1486212A (ja)
FI42245B (ja)
JPS4326732Y1 (ja)
AT279638B (ja)
JPS444281Y1 (ja)
JPS4216479Y1 (ja)
JPS4518043Y1 (ja)
JPS4314557Y1 (ja)
JPS4311183Y1 (ja)
JPS447327Y1 (ja)
BE666088A (ja)
BE658570A (ja)
SE344600B (ja)
SE314885B (ja)
NL6601032A (ja)
NL130732C (ja)
NL126286C (ja)
BE691049A (ja)
BE665425A (ja)
BE664784A (ja)
BE663471A (ja)
BE675152A (ja)
BE675253A (ja)
BE667329A (ja)